Literature DB >> 316990

Clavulanic acid and penicillin treatment of Staphylococcus aureus renal infection in mice.

M S Heerema, D M Musher, T W Williams.   

Abstract

Clavulanic acid, an inhibitor of beta-lactamase, was used together with penicillin to treat infection caused by a penicillinase-producing Staphylococcus aureus. Clavulanic acid + penicillin administered to mice, prophylactically or in treatment of established infection, reduced morbidity, bacterial counts in the kidneys, and/or mortality; these differences were statistically significant when compared with those obtained by using penicillin or clavulanic acid alone.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 316990      PMCID: PMC352956          DOI: 10.1128/AAC.16.6.798

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin.

Authors:  R Wise; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

2.  SYNERGISTIC ACTIVITY OF PENICILLINS AGAINST PENICILLINASE-PRODUCING GRAM-NEGATIVE BACILLI.

Authors:  R SUTHERLAND; F R BATCHELOR
Journal:  Nature       Date:  1964-02-29       Impact factor: 49.962

3.  Emergence of variant forms of Staphylococcus aureus after exposure to gentamicin and infectivity of the variants in experimental animals.

Authors:  D M Musher; R E Baughn; G B Templeton; J N Minuth
Journal:  J Infect Dis       Date:  1977-09       Impact factor: 5.226

4.  Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.

Authors:  C Reading; M Cole
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

5.  Effect of clavulanic acid on the minimum inhibitory concentration of benzylpenicillin, ampicillin, carbenicillin, or cephalothin against clinical isolates resistant to beta-lactam antibiotics.

Authors:  L Dumon; P Adriaens; J Anné; H Eyssen
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

6.  Mechanism of synergistic effects of beta-lactam antibiotic combinations on gram-negative bacilli.

Authors:  W E Farrar; J K Newsome
Journal:  Antimicrob Agents Chemother       Date:  1973-08       Impact factor: 5.191

7.  Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid.

Authors:  G Ninane; J Joly; M Kraytman; P Piot
Journal:  Lancet       Date:  1978-07-29       Impact factor: 79.321

8.  The inhibition of staphylococcal beta-lactamase by clavulanic acid.

Authors:  C Reading; P Hepburn
Journal:  Biochem J       Date:  1979-04-01       Impact factor: 3.857

9.  Clavulanic acid, a novel inhibitor of beta-lactamases.

Authors:  H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

10.  Effect of clavulanic acid on the in vitro synergism between carbenicillin and gentamicin against Serratia marcescens.

Authors:  T Sirisanthana; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

View more
  2 in total

1.  Clinical trial of the efficacy and safety of ticarcillin and clavulanic acid.

Authors:  G A Roselle; R Bode; B Hamilton; M Bibler; R Sullivan; R Douce; J L Staneck; W E Bullock
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

2.  Structural insights into transcriptional regulation of human RNA polymerase III.

Authors:  Qianmin Wang; Shaobai Li; Futang Wan; Youwei Xu; Zhenfang Wu; Mi Cao; Pengfei Lan; Ming Lei; Jian Wu
Journal:  Nat Struct Mol Biol       Date:  2021-02-08       Impact factor: 15.369

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.